Skip to content

Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD<sup>+</sup> in healthy middle-aged and older adults.

Published: July 22, 2026Updated: July 22, 2026

Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MBet al.

Nature Communications · 2018; 9(1):1286

This study evaluates Nicotinamide riboside (NR) 500 mg twice daily (1000 mg total per day) for 6 weeks versus matching placebo in a crossover design in relation to Safety, tolerability, and blood NAD+ levels.

Quick summary

Evidence-Based Research: Nad Precursors Aging Biorxiv

Medically reviewed by WellAlly Editorial TeamLast reviewed July 22, 2026Editorial policy

Key facts at a glance

DOI
10.1038/s41467-018-03421-7
PMID
29599478
PMC
PMC5876407
Journal
Nature Communications
Year
2018
Volume
9
Issue
1
Pages
1286
Study type
rct
Evidence level
Ib
Sample size
24
Intervention
Nicotinamide riboside (NR) 500 mg twice daily (1000 mg total per day) for 6 weeks versus matching placebo in a crossover design
Primary outcome
Safety, tolerability, and blood NAD+ levels
Follow-up
6 weeks per treatment period
Funding
government
Effect size
Blood NAD+ increased ~60% (p<0.001); systolic blood pressure reduced ~10 mmHg in elevated-BP subgroup
Registration
NCT02303483
Open access
true

Study Overview

This study examined the effects of Nicotinamide riboside (NR) 500 mg twice daily (1000 mg total per day) for 6 weeks versus matching placebo in a crossover design on Safety, tolerability, and blood NAD+ levels.

Key Findings

The results suggest the intervention has potential clinical benefits.

Clinical Conclusions

See original publication.

Abstract

"This randomized controlled trial enrolled 24 participants, investigating the effects of Nicotinamide riboside (NR) 500 mg twice daily (1000 mg total per day) for 6 weeks versus matching placebo in a crossover design on Safety, tolerability, and blood NAD+ levels.

Funding & conflicts of interest

Funding: government

COI: Some authors received research support, materials, or consulting fees from ChromaDex; related patents disclosed

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 22, 2026. · Read our editorial policy

More rct studies

View all